AYTU BIOPHARMA, INC Operating Lease, Payments
AYTU BIOPHARMA, INC (AYTU) reported Operating Lease, Payments of $182.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-09-22
- AYTU BIOPHARMA, INC operating lease, payments for the quarter ending 2026-06-30 was $82.00K, a 51.85% increase year-over-year.
- AYTU BIOPHARMA, INC operating lease, payments for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC operating lease, payments for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC operating lease, payments for the quarter ending 2025-09-30 was $100.00K, a 50.00% decline year-over-year.
- AYTU BIOPHARMA, INC operating lease, payments for fiscal 2026 was $182.00K, a 75.86% decline from fiscal 2025.
- AYTU BIOPHARMA, INC operating lease, payments for fiscal 2025 was $754.00K, a 56.24% decline from fiscal 2024.
- AYTU BIOPHARMA, INC operating lease, payments for fiscal 2024 was $1.72M, a 19.99% increase from fiscal 2023.
- AYTU BIOPHARMA, INC operating lease, payments for fiscal 2023 was $1.44M, a 41.34% increase from fiscal 2022.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $82.00K derived: sum of 2 quarters · filed 2026-09-22 | $82.00K derived: sum of 3 quarters · filed 2026-09-22 | $182.00K 10-K · filed 2026-09-22 | ||||
| 2026-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $100.00K 10-Q · filed 2026-05-13 | $154.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $100.00K 10-Q · filed 2026-02-03 | $154.00K derived: sum of 3 quarters · filed 2026-09-22 | $254.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-13 | $154.00K derived: sum of 2 quarters · filed 2026-09-22 | $254.00K derived: sum of 3 quarters · filed 2026-09-22 | $654.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-06-30 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $154.00K derived: sum of 2 quarters · filed 2026-09-22 | $554.00K derived: sum of 3 quarters · filed 2026-09-22 | $754.00K 10-K · filed 2026-09-22 | ||||
| 2025-03-31 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $500.00K derived: sum of 2 quarters · filed 2026-05-13 | $700.00K 10-Q · filed 2026-05-13 | $739.00K 10-Q · filed 2025-05-14 | $1.39M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $600.00K 10-Q · filed 2026-02-03 | $606.00K 10-Q · filed 2025-02-12 | $1.29M derived: sum of 3 quarters · filed 2026-02-03 | $1.63M derived: sum of 4 quarters · filed 2026-02-03 | |||
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-13 | $168.00K 10-Q · filed 2024-11-13 | $889.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.23M derived: sum of 3 quarters · filed 2025-11-13 | $1.56M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $689.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $1.03M derived: sum of 2 quarters · filed 2025-09-23 | $1.36M derived: sum of 3 quarters · filed 2025-09-23 | $1.72M 10-K · filed 2025-09-23 | $1.81M 10-K · filed 2024-09-26 | |||
| 2024-03-31 | $337.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $674.00K derived: sum of 2 quarters · filed 2025-05-14 | $1.03M 10-Q · filed 2025-05-14 | $1.39M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $337.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | $697.00K 10-Q · filed 2025-02-12 | $1.06M derived: sum of 3 quarters · filed 2025-02-12 | $1.42M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-09-30 | $360.00K 10-Q · filed 2024-11-13 | $720.00K derived: sum of 2 quarters · filed 2024-11-13 | $1.08M derived: sum of 3 quarters · filed 2024-11-13 | $1.44M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $360.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | $720.00K derived: sum of 2 quarters · filed 2024-09-26 | $1.08M derived: sum of 3 quarters · filed 2024-09-26 | $1.44M 10-K · filed 2024-09-26 | ||||
| 2023-03-31 | $360.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $719.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.08M 10-Q · filed 2024-05-15 | $1.15M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $359.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $716.00K 10-Q · filed 2024-02-14 | $790.00K derived: sum of 3 quarters · filed 2024-02-14 | $1.15M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | $357.00K 10-Q · filed 2023-11-14 | $431.00K derived: sum of 2 quarters · filed 2023-11-14 | $788.00K derived: sum of 3 quarters · filed 2023-11-14 | $1.09M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | $431.00K derived: sum of 2 quarters · filed 2023-10-12 | $734.00K derived: sum of 3 quarters · filed 2023-10-12 | $1.02M 10-K · filed 2023-10-12 | ||||
| 2022-03-31 | $357.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $660.00K derived: sum of 2 quarters · filed 2023-05-11 | $942.00K 10-Q · filed 2023-05-11 | $1.21M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $303.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-02-21 | $585.00K 10-Q · filed 2023-02-21 | $857.00K derived: sum of 3 quarters · filed 2023-02-21 | $927.00K derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-09-30 | $282.00K 10-Q/A · filed 2023-02-21 | $554.00K derived: sum of 2 quarters · filed 2023-02-21 | $624.00K derived: sum of 3 quarters · filed 2023-02-21 | $654.00K derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $342.00K derived: sum of 2 quarters · filed 2022-09-27 | $372.00K derived: sum of 3 quarters · filed 2022-09-27 | $467.00K 10-K · filed 2022-09-27 | ||||
| 2021-03-31 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $100.00K derived: sum of 2 quarters · filed 2022-05-16 | $195.00K 10-Q · filed 2022-05-16 | $128.00K 10-Q · filed 2021-05-17 | $322.00K derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $125.00K 10-Q · filed 2022-02-14 | $147.00K 10-Q · filed 2021-02-11 | $252.00K derived: sum of 3 quarters · filed 2022-02-14 | $261.00K derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2020-09-30 | $95.00K 10-Q · filed 2021-11-15 | $66.00K 10-Q · filed 2020-11-12 | $222.00K derived: sum of 2 quarters · filed 2021-11-15 | $231.00K derived: sum of 3 quarters · filed 2021-11-15 | $294.00K derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $136.00K derived: sum of 2 quarters · filed 2021-09-28 | $199.00K derived: sum of 3 quarters · filed 2021-09-28 | $199.00K 10-K · filed 2021-09-28 | ||||
| 2020-03-31 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | $72.00K derived: sum of 2 quarters · filed 2021-05-17 | $72.00K 10-Q · filed 2021-05-17 | |||||
| 2019-12-31 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | $63.00K 10-Q · filed 2021-02-11 | ||||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |